Why is "Estradiol/dydrogesterone" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-04-02 07:00:53
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
This topic is not currently in the ranking.
Wikipedia Overview
Estradiol/dydrogesterone (E2/DYD), sold under the brand name Femoston among others, is a combination of estradiol (E2), an estrogen, and dydrogesterone (DYD), a progestin, which is used in menopausal hormone therapy, specifically to treat and prevent hot flashes and osteoporosis, in postmenopausal women. It is taken by mouth and contains 0.5, 1, or 2 mg E2 and 2.5, 5, 10, or 20 mg DYD per tablet. The medication is marketed widely throughout the world. It is not available in the United States or Canada.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
Menopausal hormone treatment and breast cancer - The Lancet
-
This FDA Decision Could Transform Menopause Care - Ms. Magazine
-
Clinical outcomes of different 17β-estradiol drug regimens and their impact on endometrial receptivity - Frontiers
-
Gujarat set to give China stiff competition in hormone APIs - The Times of India
-
Different effects of menopausal hormone therapy on non-alcoholic fatty liver disease based on the route of estrogen administration | Scientific Reports - Nature
-
Quick Take: Use of Hormone Replacement Therapy and Risk of Venous Thromboembolism: Nested Case-Control Studies Using the QResearch and CPRD Databases - 2 Minute Medicine
-
Reproductive Medicine and Biology | Reproduction Journal - Wiley Online Library
-
Theramex gains European rights to Duphaston and Femoston from Viatris - Pharmaceutical Technology
-
Some types of HRT more risky for breast cancer - AuntMinnie
-
Low estradiol hormone levels tied to worse brain damage in menopause - Multiple Sclerosis News Today
-
Theramex Announces Agreement to Acquire the European Rights to Duphaston® and Femoston® From Viatris, Inc. - Business Wire
-
HRT tablets linked to higher blood clot risk: study - pharmaphorum
-
Oral HRT for Menopause Has Highest VTE Risk, Patches Safest - Medscape
-
Abbott gets CDSCO panel nod for importing, marketing of Estradiol, Dydrogesterone FDC - medicaldialogues.in
-
VTE Risk in Women May Be Higher With Oral vs Transdermal Hormone Replacement Therapies - TCTMD.com
-
A randomized, double blinded, placebo controlled trial of oral dydrogesterone supplementation in the management of preterm labor | Scientific Reports - Nature
-
Hemostatic changes associated with menopausal hormone therapy. Comparison of transdermal and oral administration - Termedia
-
Menopause prescribing advice updated as HRT shortage continues - GPonline
-
Sun Pharma Progesterone injection secures CDSCO panel okay - medicaldialogues.in
-
Comparison of effectiveness and tolerability of two oral low-dose formulations containing 1 mg of 17β-estradiol and either dydrogesterone or norethisterone acetate applied as continuous combined hormonal therapy in peri- and postmenopausal women - Termedia
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.